(19)
(11) EP 1 185 270 A1

(12)

(43) Date of publication:
13.03.2002 Bulletin 2002/11

(21) Application number: 00942934.1

(22) Date of filing: 16.06.2000
(51) International Patent Classification (IPC)7A61K 31/47, A61K 31/495, A61K 31/38, A61K 31/17
(86) International application number:
PCT/US0016/814
(87) International publication number:
WO 0076/517 (21.12.2000 Gazette 2000/51)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.06.1999 US 139677 P

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
PhiladelphiaPennsylvania 19103 (US)

(72) Inventors:
  • BRYAN, Deborah, L.
    West Chester, PA 19380 (US)
  • GLEASON, John, G.
    Downingtown, PA 19335 (US)
  • WIDDOWSON, Katherine, L.
    King of Prussia, PA 19406 (US)
  • BENSON, Gregory, M.
    3rd AvenueHarlowEssex CM19 5AW (GB)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) IL-8 RECEPTOR ANTAGONISTS